Application 020505

Type
NDA
Sponsor
JANSSEN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOPAMAXTOPIRAMATETABLET;ORAL100MGYesYes
002TOPAMAXTOPIRAMATETABLET;ORAL200MGYesNo
003TOPAMAXTOPIRAMATETABLET;ORAL300MGNoNo
004TOPAMAXTOPIRAMATETABLET;ORAL25MGYesNo
005TOPAMAXTOPIRAMATETABLET;ORAL50MGYesNo
006TOPAMAXTOPIRAMATETABLET;ORAL400MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
21695-128TopamaxtopiramateRebel Distributors CorpNDACurrent
21695-129TopamaxtopiramateRebel Distributors CorpNDACurrent
21695-130TopamaxtopiramateRebel Distributors CorpNDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-639TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-640TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-641TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
50458-642TopamaxtopiramateJanssen Pharmaceuticals, Inc.NDACurrent
55289-433TopamaxtopiramatePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-433TopamaxtopiramatePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-433TopamaxtopiramatePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-433TopamaxtopiramatePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-433TopamaxtopiramatePD-Rx Pharmaceuticals, Inc.NDACurrent
70518-1393TopamaxtopiramateREMEDYREPACK INC.NDACurrent
70518-1393TopamaxtopiramateREMEDYREPACK INC.NDACurrent
70518-2165TopamaxtopiramateREMEDYREPACK INC.NDACurrent
70518-2753TopamaxtopiramateREMEDYREPACK INC.NDACurrent
70518-2753TopamaxtopiramateREMEDYREPACK INC.NDACurrent
70518-2753TopamaxtopiramateREMEDYREPACK INC.NDACurrent
70518-2753TopamaxtopiramateREMEDYREPACK INC.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85350SUPPL 2026-03-12
85326SUPPL 2026-03-12
85294SUPPL 2026-03-09
81587SUPPL 2025-03-17
81556SUPPL 2025-03-14
74174SUPPL 2023-05-04
74167SUPPL 2023-05-04
72461SUPPL2022-10-24
72439SUPPL2022-10-21
69913SUPPL2022-01-19
69912SUPPL2022-01-19
69901SUPPL2022-01-19
68018SUPPL2021-07-07
68002SUPPL2021-07-01
67999SUPPL2021-07-01
63470SUPPL2020-06-09
63469SUPPL2020-06-09
63461SUPPL2020-06-09
58553SUPPL2019-05-03
58541SUPPL2019-05-03
58540SUPPL2019-05-03
57103SUPPL2019-01-02
57057SUPPL2018-12-30
57044SUPPL2018-12-28
54689SUPPL2018-06-26
54647SUPPL2018-06-21
48409SUPPL2017-05-17
48381SUPPL2017-05-16
12654SUPPL2014-12-19
2626SUPPL2014-12-19
34736SUPPL2014-10-23
2625SUPPL2014-10-23
25072SUPPL2014-04-02
34735SUPPL2014-04-01
12653SUPPL2014-01-31
25073SUPPL2014-01-30
2624SUPPL2012-11-01
34734SUPPL2012-10-29
20687SUPPL2012-02-28
2623SUPPL2011-07-19
12651SUPPL2011-07-18
25071SUPPL2011-03-08
25070SUPPL2011-03-08
12652SUPPL2011-03-04
12650SUPPL2011-03-04
34732SUPPL2010-01-04
34730SUPPL2010-01-04
34726SUPPL2010-01-04
12648SUPPL2010-01-04
25068SUPPL2009-12-30
25067SUPPL2009-12-30
2621SUPPL2009-12-30
2613SUPPL2009-12-30
34733SUPPL2009-05-12
12649SUPPL2009-05-12
25069SUPPL2009-05-04
2622SUPPL2009-05-04
34731SUPPL2009-04-28
25066SUPPL2006-10-23
25065SUPPL2005-07-08
25064SUPPL2005-07-08
34729SUPPL2005-07-05
34727SUPPL2005-07-05
20686ORIG2004-09-10
41401SUPPL2004-09-08
12647SUPPL2004-08-12
12646SUPPL2004-08-12
2620SUPPL2004-08-12
2618SUPPL2004-08-12
2612SUPPL2004-06-28
34728SUPPL2003-12-29
34725SUPPL2003-12-29
12645SUPPL2003-12-29
2615SUPPL2003-12-19
2614SUPPL2003-12-19
2616SUPPL2003-06-22
25062SUPPL2003-06-08
2619SUPPL2003-05-29
2617SUPPL2003-05-29
25063SUPPL2002-12-09
34723SUPPL2001-08-28
25060SUPPL2001-08-28
41402SUPPL2000-07-03
41400SUPPL2000-07-03
34724SUPPL1999-10-01
25061SUPPL1999-10-01
34722SUPPL1999-07-23
25059SUPPL1999-07-23
53030SUPPL1900-01-01
53029SUPPL1900-01-01
52377ORIG1900-01-01
52376ORIG1900-01-01
51495ORIG1900-01-01
51494ORIG1900-01-01